These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 6414363)

  • 1. Comparison of ceftazidime concentrations in bile and serum.
    Bouza E; Hellín T; Rodríguez-Creixems M; Martínez-Beltrán J; Loza E; Baquero F
    Antimicrob Agents Chemother; 1983 Jul; 24(1):104-6. PubMed ID: 6414363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The excretion of cefuroxime in human bile.
    Thomas MH; Dash CH; Burnand KG; Woodyer AB
    Br J Surg; 1981 Apr; 68(4):290-1. PubMed ID: 7225746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Experimental and clinical evaluation of the biliary elimination of ceftazidime].
    Brogard JM; Jehl F; Blickle JF; Monteil H; Arnaud JP
    Pathol Biol (Paris); 1986 May; 34(5):332-8. PubMed ID: 3534701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Excretion of cefamandole, cefazolin, and cephalothin into T-tube bile.
    Ratzan KR; Baker HB; Lauredo I
    Antimicrob Agents Chemother; 1978 Jun; 13(6):985-7. PubMed ID: 677864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of ceftazidime in patients with biliary tract disease.
    Walstad RA; Wiig JN; Thurmann-Nielsen E; Halvorsen TB
    Eur J Clin Pharmacol; 1986; 31(3):327-31. PubMed ID: 3539624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biliary excretion of ceftizoxime in humans.
    Brogard JM; Arnaud JP; Timmler R
    Chemotherapy; 1984; 30(4):221-6. PubMed ID: 6086245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of obstruction on the biliary excretion of cefoperazone and ceftazidime.
    Leung JW; Chan RC; Cheung SW; Sung JY; Chung SC; French GL
    J Antimicrob Chemother; 1990 Mar; 25(3):399-406. PubMed ID: 2187012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biliary excretion of moxalactam.
    Martinez OV; Levi JU; Livingstone A; Malinin TI; Zeppa R; Hutson D; Einhorn N
    Antimicrob Agents Chemother; 1981 Aug; 20(2):231-4. PubMed ID: 6456690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on absorption, distribution, metabolism and excretion of ceftazidime in Japan.
    Saito A
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():255-62. PubMed ID: 6352628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biliary excretion and tissue levels of cefuroxime. A study in eleven patients undergoing cholecystectomy.
    Severn M; Powis SJ
    J Antimicrob Chemother; 1979 Mar; 5(2):183-8. PubMed ID: 429250
    [No Abstract]   [Full Text] [Related]  

  • 11. Ceftazidime concentration in gallbladder tissue and excretion in bile.
    Shiramatsu K; Hirata K; Yamada T; Kimura H; Someya T; Usuki T; Karasawa G; Hayasaka H
    Antimicrob Agents Chemother; 1988 Oct; 32(10):1588-9. PubMed ID: 3056242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pharmacokinetics of cefotetan excretion in the unobstructed biliary tree.
    Owen AW; Manson JM; Yates RA; Adshead VM; Houghton HL; Tweedle DE
    J Antimicrob Chemother; 1983 Jan; 11 Suppl():217-21. PubMed ID: 6573320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ceftazidime--a new extended-spectrum cephalosporin.
    Gozzard DI; Geddes AM; Farrell ID; Eykyn SJ; Phillips I; Wise R; Brown RM
    Lancet; 1982 May; 1(8282):1152-6. PubMed ID: 6122940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biliary excretion of a new semisynthetic cephalosporin, cephacetrile.
    Brogard JM; Haegele P; Dorner M; Lavillaureix J
    Antimicrob Agents Chemother; 1973 Jan; 3(1):19-23. PubMed ID: 4208278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biliary concentrations of cefamandole and its use in biliary tract surgery.
    Levi JU; Livingstone AS; Martinez OV; Zeppa R; Malinin T; Hutson DG; Einhorn NC
    Scand J Infect Dis Suppl; 1980; suppl 25():55-7. PubMed ID: 6782654
    [No Abstract]   [Full Text] [Related]  

  • 16. High hepatic excretion in humans of cefpiramide, a new cephalosporin.
    Brogard JM; Jehl F; Adloff M; Blickle JF; Monteil H
    Antimicrob Agents Chemother; 1988 Sep; 32(9):1360-4. PubMed ID: 3195998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Experimental study of the biliary excretion of antibiotic (cefotiam) in the presence of biliary tract obstruction (author's transl)].
    Yoshikawa N; Tsuji Y; Sato Y; Ikeda Y; Shinada Y; Kawanishi N; Tamaki A; Kasai Y
    Jpn J Antibiot; 1979 Nov; 32(11):1101-6. PubMed ID: 513292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biliary elimination of ceftazidime.
    Brogard JM; Jehl F; Pâris-Bockel D; Blicklé JF; Adloff M; Monteil H
    J Antimicrob Chemother; 1987 May; 19(5):671-8. PubMed ID: 3301782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of ceftazidime in premature, newborn and young infants.
    Prinsloo JG; Delport SD; Moncrieff J; Paton AM
    S Afr Med J; 1984 May; 65(20):809-11. PubMed ID: 6374925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the concentrations of ceftazidime in the serum of newborn infants after intravenous and intramuscular administration.
    Boccazzi A; Rizzo M; Caccamo ML; Assael BM
    Antimicrob Agents Chemother; 1983 Dec; 24(6):955-6. PubMed ID: 6362562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.